(Q88647826)
Statements
Nemolizumab in patients with moderate-to-severe atopic dermatitis: Randomized, phase II, long-term extension study (English)
Kenji Kabashima
Masutaka Furue
Jon M Hanifin
Grazyna Pulka
Andreas Wollenberg
Ryszard Galus
Takafumi Etoh
Ryosuke Mihara
Miwa Nakano
Thomas Ruzicka